Evidence map›Paper›PMID 40890951›Full record

ArticleHeadache2025

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing.

Richard B Lipton, Jonathan Stokes, Christopher J Evans, Elizabeth Hribal, Kailee White, Katelyn Keyloun, Krutika Parikh, Pranav Gandhi, David W Dodick

Abstract read
In one paragraph

Article in Headache, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Richard B LiptonThe Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0003-2652-2897
Jonathan StokesAbbVie, North Chicago, Illinois, USA.
Christopher J EvansLumanity, Boston, Massachusetts, USA.
Elizabeth HribalLumanity, Boston, Massachusetts, USA.ORCID 0009-0000-7864-4066
Kailee WhiteLumanity, Boston, Massachusetts, USA.
Katelyn KeylounAbbVie, North Chicago, Illinois, USA.
Krutika ParikhAbbVie, North Chicago, Illinois, USA.
Pranav GandhiAbbVie, North Chicago, Illinois, USA.
David W DodickMayo Clinic, Phoenix, Arizona, USA.ORCID 0000-0002-9486-6790

Funding

AbbVie
6 · The paper itself

Abstract

objectiveThis study explores and documents the patient experience during the prodrome phase of migraine.

backgroundMigraine attacks can be divided into four stages: the prodrome (or premonitory phase), the aura, the headache phase, and postdrome. Qualitative data on the range of symptoms during the prodrome and their timing relative to headache onset are sparse. Prodromal symptoms may predict the onset of migraine headache pain and provide a clinically useful benchmark for initiation of treatment early in an attack before pain begins. DESIGN/

methodsEligible participants with a clinician-confirmed diagnosis of migraine and at least one prodromal symptom were consented, screened, and then participated in 60-min interviews. The interview guide included open-ended questions to elicit spontaneous reports and specific probes about prodromal symptoms based on a clinician-established list. A theory approach was used to analyze the qualitative data collected in interviews to identify key themes and gather insights; data were analyzed using ATLAS.ti.

resultsData collection for this study occurred from March 8, 2022, to May 16, 2022. Twenty interviews were conducted, and analyses demonstrated that concept saturation was achieved. Participants reported 36 unique prodromal symptoms, and each participant experienced a mean of 13 symptoms (standard deviation [SD] = 6.6) and a median of 11 symptoms (interquartile range [IQR] = 7.8-17.0) during the prodrome phase. The most commonly reported prodromal symptoms were nausea (n = 17/20, 85%), fatigue/tiredness (n = 16/20, 80%), sensitivity to light (n = 13/20, 65%), neck pain/stiffness (n = 12/20, 60%), and dizziness/vertigo/light-headedness (n = 10/20, 50%). Of the symptoms reported by at least four participants (n ≥ 4/20, 20%), neck pain/stiffness was rated most bothersome (8.9 out of 10) and sensitivity to light was rated most severe (8.5 out of 10). Almost 40% of all symptoms reported occurred less than 2 h before the start of migraine headache. Of the commonly reported symptoms, nausea (0.8h), sensitivity to light (1.0 h), and dizziness/vertigo/lightheadedness (2.0 h) began closest to headache onset; fatigue/tiredness (4.0 h) and neck pain/stiffness (4.8 h) were the most remote from headache onset.

conclusionThis study identified frequently reported prodromal symptoms, with participants commonly reporting that a migraine headache would follow their experience of prodrome within a 1- to 6-h window. Characterizing the prodrome experience may improve measurement strategies for the burden of migraine and create opportunities to treat during the prodromal phase to prevent the onset of moderate or severe headaches.

Indexed as

Migraine DisordersProdromal SymptomsAdultFemaleHumansMaleMiddle AgedNauseaQualitative ResearchYoung Adulthumanistic burdenmigraine prodromequalitative researchsymptoms

Identifiers

PMID40890951
PMCPMC12455446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.